Global Veterinary Oncology Market

Veterinary Oncology Market Size, Share, Growth Analysis, By Therapy(Surgery, Radiotherapy, Chemotherapy, Immunotherapy), By Animal type(Canine, and Feline), By Cancer Type(Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2515 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 92 |Figures: 76

Veterinary Oncology Market Insights

Global Veterinary Oncology Market size was valued at USD 231.4 Billion in 2022 and is poised to grow from USD 259.4 Billion in 2023 to USD 646.87 Billion in 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The primary factors driving the market are the increased prevalence of cancer in the animal population and the rising use of veterinarian cancer therapy as a form of treatment. Growing owner desire to spend on animal healthcare and government initiatives for veterinary cancer therapy are the two main market-driving factors. Growing animal healthcare spending is occurring in developed economies. Additionally, the American Veterinary Medical Association (AVMA) predicted that 1 in 4 dogs would experience neoplasia at some point in their lifetimes.

According to the American Animal Hospital Association (AAHA), neoplastic disease was the primary cause of death in 73 out of 82 dogs and the leading cause of mortality in dogs under 1 year old. Traumatic damage is frequently caused by the condition. The feline population that has been identified to carry the feline leukemia virus (FeLV) has also been reported to be one of the main sources of lymphoma in felines. Therefore, better veterinary oncology treatment for these animals is required due to the increase in cancer incidence. The COVID-19 virus is expected to alter how people interact with their pet animals.

The majority of pet owners grew closer to their animals during the nationwide lockdowns intended to stop the spread of disease. Pet owners are encouraged to prioritize pet-friendly holidays and workplaces as life returns to normal and incorporate their pets even more into their everyday routines. Spending time with their pets improved wellbeing and helped reduce stress, according to 75% of pet owners polled by the American Pet Product Association. Adoption rates in animal shelters in the U.S. increased by as much as 40% from the previous year. Market expansion is anticipated to be supported by the trend towards pet humanization.

The market is also expanding as a result of the rising number of veterinary clinical studies being conducted to assess the efficacy and safety of various oncologic treatments for pets. To aid researchers conducting prospective veterinary clinical studies, the AVMA developed a database called the AVMA Animal Health Research Database (AAHSD). The market is expected to increase throughout the forecast period as a result of such studies by researchers who are interested in veterinary oncology treatments.

The industry is also being driven by favorable government initiatives related to the treatment of veterinary cancer. For instance, the NCI (National Cancer Institute) funded the testing of veterinary oncology medicines in animals as part of a clinical trial in July 2019. Finding novel cancer treatments that will maintain the dog's quality of life was the goal of the trials made available by veterinarian medical schools around the world. As humans and dogs share a similar biology for cancer, the experiment was also done to shed light on how the veterinary oncology therapies and techniques being tested in dogs may be applied to assist people with cancer.

US Veterinary Oncology Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 231.4 Billion

Largest Segment

Canine

Fastest Growth

Canine

Growth Rate

12.10% CAGR

Global Veterinary Oncology Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Veterinary Oncology Market Segmental Analysis

The global veterinary oncology market is categorized on the basis of therapy, animal type, cancer type, and region. Based on therapy, the market is segmented into surgery, radiotherapy, chemotherapy, immunotherapy, and others. Based on animal type, the market is segmented into canine, and feline. Based on cancer type, the market is segmented into lymphoma, mast cell cancer, mammary and Squamous cell cancer, and others. Based on region the global veterinary oncology market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Analysis by Therapy

Chemotherapeutic operations are becoming more and more popular among surgeons due to their many advantages, and in 2022, the chemotherapy category held the greatest revenue share of 25%. The AAHA's oncology recommendations state that chemotherapy is a regularly used veterinary oncology treatment method in canine cancer medicine. Small animal practitioners frequently employ Tyrosine Kinase Inhibitors (TKIs) alongside various chemotherapy approaches, such as conventional, metronomic, and targeted chemotherapy. As a result, it is projected that the growing usage of chemotherapy as a method for treating cancer in dogs will fuel the expansion of the veterinarian oncology market.

Due to an increase in research studies testing the safety and effectiveness of stereotactic radiosurgery treatment (SRT) in animals, radiology treatment is administered after chemotherapy. SRT finally lessens the tumor's toxicity while helping to manage the tumor to some extent. Proton beam radiation therapy (PBRT), according to the Journal of Hematology and Oncology in 2018, attempts to administer the radiation dose on a tumor cell and intentionally to the surrounding tissue & organs with very little or no radiation effect on animals. Over the projection period, market growth will be boosted by the growing use of target-specific medicines.

Analysis by Animal type

The elevated incidence of cancer in the canine population & an increase in life expectancy caused the canine segment to lead the veterinary oncology market and account for the greatest revenue share in 2022. Researchers have also been motivated by the rising incidence of cancer in this population to conduct clinical trials using dogs as a biological model to compare veterinary oncology therapies. Over 1 million pet dogs in the U.S. are diagnosed with cancer each year, according to a PubMed report.

The government's beneficial efforts are also making a substantial contribution to the market's expansion. For example, the Competitive Oncology Trials Consortium (COTC), a division of the NIH-NCI Centre for Cancer Research, is tasked with planning and carrying out clinical trials in cancer-stricken dogs to evaluate cutting-edge oncology treatments. This programme focuses on conducting clinical trials for canine cancer patients in order to spur market expansion. These studies are also anticipated to offer future oncology therapy choices using innovative treatments under development.

Global Veterinary Oncology Market By Animal Type, 2031 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Veterinary Oncology Market Regional Insights

North America held charge of the majority of the veterinary oncologist market in 2022, accounting for a 45.0% revenue share. The category is estimated to dominate the market for the anticipated period of time. Three major aspects that contribute to the market expansion are the increasing emphasis on pet health, the presence of several pet medicine manufacturing companies, and the rapid adoption of novel pet care treatments. Along with increased government funding for pet cancer treatments in this region, the market is also being driven by the presence of industry titans in the oncology sector.

The market in Asia Pacific is anticipated to expand over the course of the forecast period as a result of expanding physician awareness of various pet treatment options, improved veterinary healthcare infrastructure, & rising animal healthcare costs.

Global Veterinary Oncology Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Veterinary Oncology Market Dynamics

Drivers

Increasing Incidence of Cancer in Animals

  • The rising prevalence of cancer in companion animals, such as dogs and cats, is a major driver of the veterinary oncology market. Pets are living longer, and like humans, they are susceptible to developing cancer as they age. This drives the demand for effective oncology treatments.

Restraints

Cost of Veterinary Oncology Treatments

  • The cost of veterinary oncology treatments can be a significant restraint for many pet owners. Cancer treatments can be expensive, involving diagnostic tests, surgeries, medications, and follow-up care. The high cost of treatment may limit the accessibility and affordability of veterinary oncology services.

Request Free Customization of this report to help us to meet your business objectives.

Veterinary Oncology Market Competitive Landscape

The market for veterinary oncology is seeing intense competition as a result of the availability of oncology treatments for veterinary use from numerous large pharmaceutical and medical device businesses. To expand their revenue share and establish their presence, market participants are concentrating on putting new tactics into practice, such as regional growth, mergers, acquisitions, the introduction of new products, collaborations, and distribution agreements. Following Elanco's acquisition of Aratana Therapeutics in, the corporation announced the creation of a commercial team focused on the veterinary specialty market.

Additionally, in the same year, PharmAust in Australia began a Phase 2 clinical trial with their top veterinary medication candidate, monepantel, to treat canine cancer. This was another contribution from the market player. As a repurposed anti-cancer medication for veterinary cancer, PharmAust patented & reformulated monepantel and intends to enter into a deal with Elanco for this application. As a result, the company's development will be sped up by the modification of these types of medications for veterinary oncology therapy, which will also spur market expansion.

Top Player’s Company Profiles

  • Zoetis
  • Elanco Animal Health
  • IDEXX Laboratories
  • Veterinary Cancer Group
  • Ethos Veterinary Health
  • VCA (Veterinary Centers of America)
  • BluePearl Veterinary Partners
  • Anivive Lifesciences
  • Aratana Therapeutics (Part of Elanco Animal Health)
  • Oncolytics Biotech Inc.
  • VetDC
  • Rhizen Pharmaceuticals
  • AB Science
  • VetCell Therapeutics
  • Vet-Stem, Inc.
  • Nexvet (Part of Zoetis)
  • Pegasus Laboratories (Part of Merck Animal Health)
  • Biomedica Management Corporation
  • Sentinel Biomedical
  • Karyopharm Therapeutics

Recent Developments

  • November 2023 A clinical research to assess the efficacy of BIOCERA-VET® Osteosarcoma Cementoplasty in conjunction with Stereotactic Radiotherapy (SRT) for patients diagnosed with osteosarcoma has been launched, according to TheraVet, a leader in the pet sector for treating osteoarticular disease.

     

  • Hemangiosarcoma (HSA) is a frequent and aggressive canine disease. FidoCure presented study findings in September 2023 outlining several precision medicine methods for clinicians to comprehend HSA. For dog owners, receiving an HSA diagnosis can be distressing because it requires a painful and drawn-out diagnosing process. Therefore, hemangiosarcoma genome sequencing can yield information that will enable vets to better understand the prognosis of HSA patients and empower pet parents to make decisions about their pets' lives and deaths.

     

  • In July 2023, FidoCure and Ardent Animal Health teamed to use the latter's precision medicine and genomic testing technology to increase access to oncology breakthroughs in veterinary health.

Veterinary Oncology Key Market Trends

  • Increasing Focus on Personalized Medicine: Similar to human oncology, there is a growing trend in veterinary oncology towards personalized medicine. This approach involves tailoring treatment plans based on the specific characteristics of an individual animal's cancer, such as genetic mutations or biomarkers. Personalized medicine aims to improve treatment outcomes and minimize adverse effects.
  • Growth of Immunotherapy: Immunotherapy, which harnesses the body's immune system to fight cancer, is gaining momentum in veterinary oncology. It involves the use of vaccines, immune checkpoint inhibitors, and other immunomodulatory agents to stimulate or enhance the immune response against cancer cells. Immunotherapy offers promising results and is being explored for various types of cancers in animals.
  • Rise in Targeted Therapies: Targeted therapies are drugs or treatments designed to specifically target cancer cells or their specific molecular pathways. They aim to disrupt cancer cell growth and survival while minimizing damage to healthy cells. The development of targeted therapies is on the rise in veterinary oncology, providing new treatment options with potentially fewer side effects.
  • Integration of Advanced Diagnostic Imaging: Advanced diagnostic imaging techniques, such as positron emission tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI), are increasingly utilized in veterinary oncology. These imaging modalities offer detailed visualization of tumors, aiding in accurate staging, treatment planning, and monitoring of treatment response.

Veterinary Oncology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global veterinary oncology market analysis, the primary factors driving market expansion are the increased prevalence of cancer in the animal population and the rising use of veterinarian cancer therapy as a form of treatment. Growing owner desire to spend on animal healthcare and government initiatives for veterinary cancer therapy are the two main market-driving factors. Growing animal healthcare spending is occurring in developed economies. Additionally, the American Veterinary Medical Association (AVMA) predicted that 1 in 4 dogs would experience neoplasia at some point in their lifetimes.

Report Metric Details
Market size value in 2031 USD 231.4 Billion
Growth Rate 12.10%
Forecast period 2024-2031
Segments covered
  • Therapy
    • Surgery, Radiotherapy, Chemotherapy, Immunotherapy, and Others
  • Animal type
    • Canine, and Feline
  • Cancer Type
    • Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Zoetis
  • Elanco Animal Health
  • IDEXX Laboratories
  • Veterinary Cancer Group
  • Ethos Veterinary Health
  • VCA (Veterinary Centers of America)
  • BluePearl Veterinary Partners
  • Anivive Lifesciences
  • Aratana Therapeutics (Part of Elanco Animal Health)
  • Oncolytics Biotech Inc.
  • VetDC
  • Rhizen Pharmaceuticals
  • AB Science
  • VetCell Therapeutics
  • Vet-Stem, Inc.
  • Nexvet (Part of Zoetis)
  • Pegasus Laboratories (Part of Merck Animal Health)
  • Biomedica Management Corporation
  • Sentinel Biomedical
  • Karyopharm Therapeutics
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Veterinary Oncology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Veterinary Oncology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Veterinary Oncology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Veterinary Oncology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Veterinary Oncology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Veterinary Oncology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Veterinary Oncology Market size was valued at USD 231.4 Billion in 2022 and is poised to grow from USD 259.4 Billion in 2023 to USD 646.87 Billion in 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The market for veterinary oncology is seeing intense competition as a result of the availability of oncology treatments for veterinary use from numerous large pharmaceutical and medical device businesses. To expand their revenue share and establish their presence, market participants are concentrating on putting new tactics into practice, such as regional growth, mergers, acquisitions, the introduction of new products, collaborations, and distribution agreements. Following Elanco's acquisition of Aratana Therapeutics in, the corporation announced the creation of a commercial team focused on the veterinary specialty market. 'Zoetis', 'Elanco Animal Health', 'IDEXX Laboratories', 'Veterinary Cancer Group', 'Ethos Veterinary Health', 'VCA (Veterinary Centers of America)', 'BluePearl Veterinary Partners', 'Anivive Lifesciences', 'Aratana Therapeutics (Part of Elanco Animal Health)', 'Oncolytics Biotech Inc.', 'VetDC', 'Rhizen Pharmaceuticals', 'AB Science', 'VetCell Therapeutics', 'Vet-Stem, Inc.', 'Nexvet (Part of Zoetis)', 'Pegasus Laboratories (Part of Merck Animal Health)', 'Biomedica Management Corporation', 'Sentinel Biomedical', 'Karyopharm Therapeutics'

The rising prevalence of cancer in companion animals, such as dogs and cats, is a major driver of the veterinary oncology market. Pets are living longer, and like humans, they are susceptible to developing cancer as they age. This drives the demand for effective oncology treatments.

Increasing Focus on Personalized Medicine: Similar to human oncology, there is a growing trend in veterinary oncology towards personalized medicine. This approach involves tailoring treatment plans based on the specific characteristics of an individual animal's cancer, such as genetic mutations or biomarkers. Personalized medicine aims to improve treatment outcomes and minimize adverse effects.

North America held charge of the majority of the veterinary oncologist market in 2022, accounting for a 45.0% revenue share. The category is estimated to dominate the market for the anticipated period of time. Three major aspects that contribute to the market expansion are the increasing emphasis on pet health, the presence of several pet medicine manufacturing companies, and the rapid adoption of novel pet care treatments. Along with increased government funding for pet cancer treatments in this region, the market is also being driven by the presence of industry titans in the oncology sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Veterinary Oncology Market

Product ID: SQMIG35A2515

$5,300
BUY NOW GET FREE SAMPLE